These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 9857096)
1. Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers. Dinkova-Kostova AT; Abeygunawardana C; Talalay P J Med Chem; 1998 Dec; 41(26):5287-96. PubMed ID: 9857096 [TBL] [Abstract][Full Text] [Related]
2. Induction of glutathione transferases and NAD(P)H:quinone reductase by fumaric acid derivatives in rodent cells and tissues. Spencer SR; Wilczak CA; Talalay P Cancer Res; 1990 Dec; 50(24):7871-5. PubMed ID: 2123743 [TBL] [Abstract][Full Text] [Related]
3. The potency of inducers of NAD(P)H:(quinone-acceptor) oxidoreductase parallels their efficiency as substrates for glutathione transferases. Structural and electronic correlations. Spencer SR; Xue LA; Klenz EM; Talalay P Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):711-7. PubMed ID: 1900000 [TBL] [Abstract][Full Text] [Related]
4. Regulation of enzymes that detoxify the electrophilic forms of chemical carcinogens. Talalay P; Prochaska HJ; Spencer SR Princess Takamatsu Symp; 1990; 21():177-87. PubMed ID: 2134677 [TBL] [Abstract][Full Text] [Related]
5. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Dinkova-Kostova AT; Massiah MA; Bozak RE; Hicks RJ; Talalay P Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3404-9. PubMed ID: 11248091 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Zhang Y; Talalay P Cancer Res; 1998 Oct; 58(20):4632-9. PubMed ID: 9788615 [TBL] [Abstract][Full Text] [Related]
7. Constituents of the stem bark of Pongamia pinnata with the potential to induce quinone reductase. Carcache-Blanco EJ; Kang YH; Park EJ; Su BN; Kardono LB; Riswan S; Fong HH; Pezzuto JM; Kinghorn AD J Nat Prod; 2003 Sep; 66(9):1197-202. PubMed ID: 14510596 [TBL] [Abstract][Full Text] [Related]
8. Induction of quinone reductase activity by psoralidin isolated from Psoralea corylifolia in mouse hepa 1c1c7 cells. Lee SJ; Nam KW; Mar W Arch Pharm Res; 2009 Jul; 32(7):1061-5. PubMed ID: 19641888 [TBL] [Abstract][Full Text] [Related]
9. Identification of chalcones as in vivo liver monofunctional phase II enzymes inducers. Cabrera M; Lavaggi ML; Croce F; Celano L; Thomson L; Fernández M; Pintos C; Raymondo S; Bollati M; Monge A; López de Ceráin A; Piro OE; Cerecetto H; González M Bioorg Med Chem; 2010 Jul; 18(14):5391-9. PubMed ID: 20639112 [TBL] [Abstract][Full Text] [Related]
10. Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Prochaska HJ; Talalay P Cancer Res; 1988 Sep; 48(17):4776-82. PubMed ID: 3409219 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of new 4-hydroxy bis-coumarins as radical scavengers and chain-breaking antioxidants. Kancheva VD; Boranova PV; Nechev JT; Manolov II Biochimie; 2010 Sep; 92(9):1138-46. PubMed ID: 20211681 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of almond skin polyphenols for scavenging free radicals and inducing quinone reductase. Chen CY; Blumberg JB J Agric Food Chem; 2008 Jun; 56(12):4427-34. PubMed ID: 18512942 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of induction of enzymes that protect against chemical carcinogenesis. Talalay P Adv Enzyme Regul; 1989; 28():237-50. PubMed ID: 2696344 [TBL] [Abstract][Full Text] [Related]
14. Protection against cancer by plant phenylpropenoids: induction of mammalian anticarcinogenic enzymes. Dinkova-Kostova AT Mini Rev Med Chem; 2002 Dec; 2(6):595-610. PubMed ID: 12370043 [TBL] [Abstract][Full Text] [Related]
15. Functionalized 3-benzylidene-indolin-2-ones: inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity. Zhang W; Go ML Bioorg Med Chem; 2009 Mar; 17(5):2077-90. PubMed ID: 19200740 [TBL] [Abstract][Full Text] [Related]
16. Relation of structure of curcumin analogs to their potencies as inducers of Phase 2 detoxification enzymes. Dinkova-Kostova AT; Talalay P Carcinogenesis; 1999 May; 20(5):911-4. PubMed ID: 10334211 [TBL] [Abstract][Full Text] [Related]
17. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
18. Searching phase II enzymes inducers, from Michael acceptor-[1,2]dithiolethione hybrids, as cancer chemopreventive agents. Couto M; de Ovalle S; Cabrera M; Cerecetto H; González M Future Med Chem; 2015; 7(7):857-71. PubMed ID: 26061105 [TBL] [Abstract][Full Text] [Related]
19. Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells. Miranda CL; Aponso GL; Stevens JF; Deinzer ML; Buhler DR Cancer Lett; 2000 Feb; 149(1-2):21-9. PubMed ID: 10737704 [TBL] [Abstract][Full Text] [Related]